TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 7988256

Group type: EXPERIMENTAL
Intervention: Surgical resection (lobectomy, pneumonectomy, other procedures)
Number of subjects: 783

Group type: COMPARATOR
Intervention: Lobectomy
Number of subjects: 783

Group type: COMPARATOR
Intervention: Pneumonectomy
Number of subjects: 783

Group type: COMPARATOR
Intervention: Simple resection
Number of subjects: 783

Group type: COMPARATOR
Intervention: Extended resection
Number of subjects: 783

Group type: EXPERIMENTAL
Intervention: Patients age 60 or older
Number of subjects: 783

Group type: EXPERIMENTAL
Intervention: Men
Number of subjects: 783

Group type: EXPERIMENTAL
Intervention: Patients with Karnofsky index < 90
Number of subjects: 783
Study: 2536538

Group type: EXPERIMENTAL
Intervention: Sodium lactate infusion
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate infusion
Number of subjects: 42
Study: 29344729

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate (NaHCO3) supplementation (0.3 g kg bm-1)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo (sodium chloride, 0.21 g kg bm-1)
Number of subjects: 11
Study: 27315514

Group type: EXPERIMENTAL
Intervention: 50 mg DCS administered 1 hr prior to the final three sessions of CBT
Number of subjects: 180

Group type: COMPARATOR
Intervention: Matching placebo administered 1 hr prior to the final three sessions of CBT
Number of subjects: 180
Study: 25661281

Group type: EXPERIMENTAL
Intervention: Tiotropium 5 μg once-daily
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Tiotropium 2.5 μg twice-daily
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Tiotropium (both dosing regimens)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94
Study: 23161599

Group type: EXPERIMENTAL
Intervention: Buprenorphine (mean dose: 14.00 mg)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Methadone (mean dose: 52.50 mg)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Voucher-based incentives for attendance and completion of study assessments
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Escalating voucher incentives for drug-free urine samples (MOTHER-trial only)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Oral morphine solution for neonatal abstinence syndrome treatment
Number of subjects: 59
Study: 21903536

Group type: EXPERIMENTAL
Intervention: Total-etch adhesive system with diamond bur preparation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Total-etch adhesive system with Er:YAG laser preparation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Self-etch adhesive system with diamond bur preparation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Self-etch adhesive system with Er:YAG laser preparation
Number of subjects: 0
Study: 18353012

Group type: EXPERIMENTAL
Intervention: Fluorescence-controlled Er:YAG laser at threshold levels 9 and 10 [U]
Number of subjects: 26

Group type: COMPARATOR
Intervention: Conventional bur treatment
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Fluorescence-controlled Er:YAG laser
Number of subjects: 26
Study: 16115991

Group type: EXPERIMENTAL
Intervention: morphine + ketamine (n = 8)
Number of subjects: 24

Group type: COMPARATOR
Intervention: placebo + ketamine (n = 8)
Number of subjects: 24

Group type: COMPARATOR
Intervention: morphine + placebo (n = 8)
Number of subjects: 24
Study: 12693594

Group type: EXPERIMENTAL
Intervention: Urine culture
Number of subjects: 1661

Group type: EXPERIMENTAL
Intervention: Urine microscopy
Number of subjects: 1661

Group type: EXPERIMENTAL
Intervention: Antibiotic sensitivity testing
Number of subjects: 1661
Study: 10373809

Group type: EXPERIMENTAL
Intervention: Self-paced, distance education package on violence against women (8 weeks duration, 7 modules including written and audio material, mentor and teleconference support)
Number of subjects: 60
Study: 7472824

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) treatment
Number of subjects: 139
Study: 2137066

Group type: EXPERIMENTAL
Intervention: Sorbinil (250 mg day-1)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Sorbinil
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 21
Study: 7011622

Group type: EXPERIMENTAL
Intervention: 3 g/24 hr frusemide (sustained)
Number of subjects: 58

Group type: COMPARATOR
Intervention: 1 g frusemide (single injection)
Number of subjects: 58
Study: 31826009

Group type: EXPERIMENTAL
Intervention: Porous acupuncture (PA)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Original acupuncture (OA)
Number of subjects: 21
Study: 28323139

Group type: EXPERIMENTAL
Intervention: Physical rehabilitation + Progressive strength training (PST)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Physical rehabilitation
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Surgery-induced inflammation
Number of subjects: 72
Study: 25938629

Group type: COMPARATOR
Intervention: MET only (BRIEF)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: THERAPIST (MET/CBT/CM)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: COMPUTER (MET/CBT/CM)
Number of subjects: 75
Study: 23369645

Group type: EXPERIMENTAL
Intervention: 30 mg oxycodone
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 21353750

Group type: EXPERIMENTAL
Intervention: Waterpipe tobacco smoking (40% ever smoked, 17% current use)
Number of subjects: 3770

Group type: EXPERIMENTAL
Intervention: Correlates of waterpipe use
Number of subjects: 3770
Study: 19950571

Group type: EXPERIMENTAL
Intervention: Terlipressin
Number of subjects: 305
Study: 18056333

Group type: EXPERIMENTAL
Intervention: Cardiac resynchronization therapy (CRT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nuclear imaging (gated myocardial perfusion SPECT with phase analysis)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nuclear imaging (SPECT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nuclear imaging (PET)
Number of subjects: 0
Study: 14729881

Group type: EXPERIMENTAL
Intervention: MBvO gymnastics twice weekly (MBvO2; n = 68)
Number of subjects: 386

Group type: EXPERIMENTAL
Intervention: MBvO gymnastics once weekly (MBvO1; n = 125)
Number of subjects: 386

Group type: COMPARATOR
Intervention: Health education programme (Control; n = 193)
Number of subjects: 386
Study: 11854673

Group type: EXPERIMENTAL
Intervention: Posterior crown margins
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Poor oral hygiene before treatment
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Plaque accumulation
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Location of crown margins
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Type of alloy
Number of subjects: 240
Study: 9647679

Group type: EXPERIMENTAL
Intervention: Factor analysis of 10 measures from 9 lateralized tasks
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Extraction and oblique rotation of five factors
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Principal-components analysis
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Local structure analysis
Number of subjects: 290
Study: 7926910

Group type: EXPERIMENTAL
Intervention: 4-aminosalicylic acid (4-ASA) 1.5 g/d, slow release tablets
Number of subjects: 40

Group type: COMPARATOR
Intervention: 5-aminosalicylic acid (5-ASA) 1.5 g/d, slow release tablets
Number of subjects: 40
Study: 3135011

Group type: EXPERIMENTAL
Intervention: Whole cell pertussis vaccine (3 doses, one month apart)
Number of subjects: 1140

Group type: COMPARATOR
Intervention: Control (unvaccinated)
Number of subjects: 1140

Group type: EXPERIMENTAL
Intervention: Whole cell pertussis vaccine
Number of subjects: 1140
Study: 31305450

Group type: EXPERIMENTAL
Intervention: fentanyl-based intravenous patient-controlled analgesia with low dose of ketamine (fk-IVPCA)
Number of subjects: 70

Group type: COMPARATOR
Intervention: thoracic patient-controlled epidural analgesia (t-PCEA)
Number of subjects: 70
Study: 27811630

Group type: EXPERIMENTAL
Intervention: Colorado needle
Number of subjects: 101

Group type: COMPARATOR
Intervention: Scalpel
Number of subjects: 101
Study: 24107877

Group type: EXPERIMENTAL
Intervention: noojerone (memantine) in addition to standard therapy for 6 months
Number of subjects: 45

Group type: COMPARATOR
Intervention: standard therapy only
Number of subjects: 45
Study: 21669163

Group type: EXPERIMENTAL
Intervention: Wrist-ankle acupuncture
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 60
Study: 19848371

Group type: EXPERIMENTAL
Intervention: Optimized aspheric transition zone algorithm (OATz group)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Wavefront-guided optimized path difference custom aspheric treatment (OPDCAT group)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Comparison of both groups
Number of subjects: 23
Study: 17006746

Group type: EXPERIMENTAL
Intervention: Tiotropium (18 mcg)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Tiotropium
Number of subjects: 44
Study: 12735584

Group type: EXPERIMENTAL
Intervention: Suction
Number of subjects: 100

Group type: COMPARATOR
Intervention: Water Seal
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 100
Study: 10702171

Group type: EXPERIMENTAL
Intervention: Amino acid supplementation during hemodialysis
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Amino acid supplementation after 3 months
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control group (no amino acid supplementation)
Number of subjects: 17
Study: 9357360

Group type: EXPERIMENTAL
Intervention: Brochures with informational messages
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Brochures with emotional messages
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Brochures with social messages
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 8448072

Group type: EXPERIMENTAL
Intervention: Captopril (25 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Enalapril (10 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 3606915

Group type: EXPERIMENTAL
Intervention: i.v. lignocaine 1.5 mg kg‐1 plus 2 mg kg‐1 h‐1
Number of subjects: 18

Group type: COMPARATOR
Intervention: saline
Number of subjects: 18
Study: 29581536

Group type: EXPERIMENTAL
Intervention: d-amphetamine (20 mg)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 28069870

Group type: EXPERIMENTAL
Intervention: Graphic warning labels
Number of subjects: 642
Study: 26081662

Group type: EXPERIMENTAL
Intervention: Hemoperfusion plus hemodialysis (HP+HD)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Low-flux hemodialysis (HD)
Number of subjects: 66

Group type: COMPARATOR
Intervention: High-flux hemodialysis (HD)
Number of subjects: 66
Study: 23115322

Group type: EXPERIMENTAL
Intervention: Low-dose beta-blockers
Number of subjects: 957

Group type: EXPERIMENTAL
Intervention: High-dose beta-blockers
Number of subjects: 957

Group type: EXPERIMENTAL
Intervention: Beta-blocker dose
Number of subjects: 957

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 957
Study: 22010234

Group type: EXPERIMENTAL
Intervention: Bacillus subtilis KD1 at 10^9, 5 × 10^9, and 10^10 bacilli/kg of feed
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 18598160

Group type: EXPERIMENTAL
Intervention: Novolizer
Number of subjects: 29

Group type: COMPARATOR
Intervention: Aerolizer
Number of subjects: 29
Study: 19657788

Group type: EXPERIMENTAL
Intervention: Flow-mediated reactive hyperemia by digital tonometry (RHI)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Body mass index
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: High density lipoprotein cholesterol
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Carotid intima-media thickness (CIMT)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Coronary arterial calcium (CAC)
Number of subjects: 102
Study: 15573391

Group type: EXPERIMENTAL
Intervention: Intrathoracic fibrinolysis with urokinase after chest tube drainage
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Antibiotic therapy
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Chest drain insertion
Number of subjects: 100

Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 100
Study: 12011823

Group type: EXPERIMENTAL
Intervention: Flurbiprofen 12.5 mg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Flurbiprofen 5.0 mg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Flurbiprofen 2.5 mg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Flurbiprofen (all dosages)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Flurbiprofen (per mg increase)
Number of subjects: 100
Study: 9972338

Group type: EXPERIMENTAL
Intervention: Brimonidine 0.2%
Number of subjects: 30
Study: 7914122

Group type: EXPERIMENTAL
Intervention: Proxodolol (Pd) single dose of 0.04-0.08 g
Number of subjects: 12

Group type: COMPARATOR
Intervention: Propranolol (Pr) single dose of 0.04-0.08 g
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Proxodolol (Pd) course treatment mean daily dose of 186 +/- 24 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Propranolol (Pr) course treatment mean daily dose of 182 +/- 25 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Proxodolol (Pd) single dose of 0.04 g
Number of subjects: 12

Group type: COMPARATOR
Intervention: Propranolol (Pr) single dose of 0.04 g
Number of subjects: 12

Group type: COMPARATOR
Intervention: Proxodolol (Pd) and Propranolol (Pr) during course therapy
Number of subjects: 12
Study: 3378465

Group type: EXPERIMENTAL
Intervention: Cefamandole (preoperative and four postoperative doses)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control (no parenteral antibiotics)
Number of subjects: 70
Study: 31112380

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 4000

Group type: COMPARATOR
Intervention: Usual care (propofol, midazolam, or other sedatives)
Number of subjects: 4000

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 4000
Study: 29212515

Group type: EXPERIMENTAL
Intervention: Baricitinib
Number of subjects: 0
Study: 26773539

Group type: EXPERIMENTAL
Intervention: Neck stretching exercises
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no stretching exercises)
Number of subjects: 80
Study: 24589330

Group type: EXPERIMENTAL
Intervention: 1-4 skeletal metastases
Number of subjects: 561

Group type: EXPERIMENTAL
Intervention: 5-20 skeletal metastases
Number of subjects: 561

Group type: EXPERIMENTAL
Intervention: >20 skeletal metastases
Number of subjects: 561

Group type: COMPARATOR
Intervention: ≥5 skeletal metastases
Number of subjects: 561
Study: 21842333

Group type: EXPERIMENTAL
Intervention: Intimate partner violence prevention program (Building a Lasting Love, 4 sessions)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 72
Study: 19200607

Group type: EXPERIMENTAL
Intervention: Gambling Symptom Assessment Scale (G‐SAS)
Number of subjects: 207
Study: 17551662

Group type: EXPERIMENTAL
Intervention: Calcipotriol and betamethasone dipropionate (Dovobet/Daivobet/Taclonex)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 15287544

Group type: EXPERIMENTAL
Intervention: Calcium hydroxide paste with distilled water
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Calcium hydroxide paste with anesthetic solution
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Calcium hydroxide paste with camphorated p‐monochlorophenol
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Calcium hydroxide paste with camphorated p‐monochlorophenol‐propylene glycol
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: All calcium hydroxide pastes
Number of subjects: 180
Study: 11204805

Group type: EXPERIMENTAL
Intervention: LC-1 (acidified milk)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study: 9596107

Group type: EXPERIMENTAL
Intervention: Regular inhaled beta2-agonist (fenoterol) treatment
Number of subjects: 64
Study: 7786691

Group type: EXPERIMENTAL
Intervention: Magnesium 15 mmol/day
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 3149455

Group type: EXPERIMENTAL
Intervention: Buserelin (200 micrograms subcutaneously daily or 400 micrograms intranasally three times daily)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Buserelin
Number of subjects: 160

Group type: COMPARATOR
Intervention: DES/orchiectomy
Number of subjects: 160

Group type: COMPARATOR
Intervention: Buserelin and DES/orchiectomy
Number of subjects: 160
Study: 29338146

Group type: EXPERIMENTAL
Intervention: High liberal group (15 mL/kg/hr intraoperatively and 10 mL/kg/hr six hours postoperatively)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Low liberal group (5 mL/kg/hr intraoperatively and six hours postoperatively)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Restrictive group (1 mL/kg/hr intraoperatively and six hours postoperatively)
Number of subjects: 90
Study: 25780260

Group type: EXPERIMENTAL
Intervention: Schroth's 3D exercises in the clinic
Number of subjects: 51

Group type: COMPARATOR
Intervention: Schroth's 3D exercises at home
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 51
Study: 24201760

Group type: EXPERIMENTAL
Intervention: Real peripheral prism glasses (57-prism diopter oblique)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Sham peripheral prism glasses (<5-prism diopter horizontal)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Real peripheral prism glasses
Number of subjects: 73

Group type: COMPARATOR
Intervention: Sham peripheral prism glasses
Number of subjects: 73
Study: 23422913

Group type: EXPERIMENTAL
Intervention: BC-3781 100 mg
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: BC-3781 150 mg
Number of subjects: 210

Group type: COMPARATOR
Intervention: Vancomycin 1 g every 12 h
Number of subjects: 210

Group type: COMPARATOR
Intervention: Vancomycin
Number of subjects: 210
Study: 20825674

Group type: EXPERIMENTAL
Intervention: Uncontrolled asthma
Number of subjects: 473
Study: 17579613

Group type: EXPERIMENTAL
Intervention: Cryoablation (CRYO)
Number of subjects: 64

Group type: COMPARATOR
Intervention: External beam radiation (EBRT)
Number of subjects: 64
Study: 16970093

Group type: EXPERIMENTAL
Intervention: Yuquan Pill (YP) 6 g four times a day for 3 months
Number of subjects: 90

Group type: COMPARATOR
Intervention: Glucobay with dietary and exercise therapy for 3 months (Control)
Number of subjects: 90
Study: 12113275

Group type: EXPERIMENTAL
Intervention: Computer-aided diagnosis
Number of subjects: 80

Group type: COMPARATOR
Intervention: Contrast radiography
Number of subjects: 80
Study: 9987507

Group type: EXPERIMENTAL
Intervention: Dexamethasone 4 mg/day
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Metoclopramide 40 mg/day
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Ondansetron 4 mg/day
Number of subjects: 17
Study: 8846678

Group type: EXPERIMENTAL
Intervention: Insulin and glibenclamide
Number of subjects: 10

Group type: COMPARATOR
Intervention: Insulin alone
Number of subjects: 10

Group type: COMPARATOR
Intervention: Insulin and placebo
Number of subjects: 10
Study: 2227085

Group type: EXPERIMENTAL
Intervention: 0.1% topical tretinoin
Number of subjects: 0
Study: 681614

Group type: EXPERIMENTAL
Intervention: Expectancy set condition with belief of consuming alcohol
Number of subjects: 48

Group type: COMPARATOR
Intervention: Expectancy set condition with belief of consuming nonalcoholic beverage
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Alcoholic malt liquor
Number of subjects: 48

Group type: COMPARATOR
Intervention: Nonalcoholic malt beverage
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Cognitive set (expectancy)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Alcohol
Number of subjects: 48
Study: 28737282

Group type: EXPERIMENTAL
Intervention: Twisted and stained teeth
Number of subjects: 433

Group type: COMPARATOR
Intervention: White and aligned teeth
Number of subjects: 433

Group type: EXPERIMENTAL
Intervention: Participants with ≥20 teeth
Number of subjects: 433

Group type: COMPARATOR
Intervention: Participants with <20 teeth
Number of subjects: 433

Group type: EXPERIMENTAL
Intervention: Women with twisted and stained teeth
Number of subjects: 433

Group type: EXPERIMENTAL
Intervention: Men with twisted and stained teeth
Number of subjects: 433
Study: 27364603

Group type: EXPERIMENTAL
Intervention: COPD Assessment Test (CAT) administered at baseline, 1.5 years, and 3 years.
Number of subjects: 716

Group type: EXPERIMENTAL
Intervention: COPD Assessment Test (CAT) administered to distinguish between exacerbation status.
Number of subjects: 716

Group type: EXPERIMENTAL
Intervention: COPD Assessment Test (CAT) administered to different demographic groups.
Number of subjects: 716
Study: 24731917

Group type: EXPERIMENTAL
Intervention: 6-month exercise and hypocaloric healthy eating program plus usual care
Number of subjects: 85

Group type: COMPARATOR
Intervention: usual care alone
Number of subjects: 85
Study: 22420843

Group type: EXPERIMENTAL
Intervention: sirolimus
Number of subjects: 86

Group type: COMPARATOR
Intervention: CNI
Number of subjects: 86
Study: 20679551

Group type: EXPERIMENTAL
Intervention: Paramedic cooling with rapid infusion of 2 L of ice-cold lactated Ringer's solution
Number of subjects: 234

Group type: COMPARATOR
Intervention: Hospital cooling (cooling after hospital admission)
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: Paramedic cooling
Number of subjects: 234

Group type: COMPARATOR
Intervention: Hospital cooling
Number of subjects: 234
Study: 18602242

Group type: EXPERIMENTAL
Intervention: Pictographs (image matrices)
Number of subjects: 631

Group type: COMPARATOR
Intervention: Numeric text only
Number of subjects: 631

Group type: EXPERIMENTAL
Intervention: Incremental risk formats
Number of subjects: 631
Study: 16330196

Group type: EXPERIMENTAL
Intervention: Oral montelukast for 4 weeks
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group (no preventive treatment)
Number of subjects: 23
Study: 12817518

Group type: EXPERIMENTAL
Intervention: CYP3A5 and MDR1 polymorphic expression
Number of subjects: 19

Group type: COMPARATOR
Intervention: MDR1 C3435T genotype
Number of subjects: 19
Study: 10937516

Group type: EXPERIMENTAL
Intervention: Dilazep dihydrochloride (300 mg/day)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 9132333

Group type: EXPERIMENTAL
Intervention: Primary fibromyalgia patients
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (age and sex matched)
Number of subjects: 32